Amarin Corp Plc (AMRN)

[mclim]

Sam, on the yahoo boards, someone contacted symphony and here is what they replied with.

Thank you for your recent inquiry to Symphony Health regarding data related to Amarin and rumors of issues with that data. We appreciate the opportunity to address your concerns. With regard to Amarin, and specifically the drug Vascepa, we did have a vendor that comprises less than 14% of sample have an interruption in reporting. As is our normal course of business when vendors experience a delay or interruption in reporting, we adjusted our projection factors to account for this data. We published a restatement for the weeks ending 3/8, 3/15 and 3/22 and have been in contact with Amarin related to this restatement. We are pleased to report that our numbers are trending accurately.

Should you need any further information, please don’t hesitate to contact me.

Kind regards,

Heather Varela
Director, Marketing Communications